SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-016840
Filing Date
2019-08-28
Accepted
2019-08-28 10:50:32
Documents
4
Period of Report
2019-08-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k082819_biondvaxpharma.htm 6-K 11229
2 PRESS RELEASE DATED AUGUST 28, 2019 f6k082819ex99-1_biondvax.htm EX-99.1 89887
3 GRAPHIC ex99-1_001.jpg GRAPHIC 7555
4 GRAPHIC ex99-1_002.jpg GRAPHIC 18554
  Complete submission text file 0001213900-19-016840.txt   138358
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 191059578
SIC: 2836 Biological Products, (No Diagnostic Substances)